Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 1101 to 1150 of 2027

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Biomarker tests to help diagnose preterm labour in women with intact membranesHTG476
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapyTA530
Beta interferons and glatiramer acetate for treating multiple sclerosisTA527
Dementia: assessment, management and support for people living with dementia and their carersNG97
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's diseaseTA217
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorHTG474
Laparoscopic ventral mesh rectopexy for internal rectal prolapseHTG475
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526
Guselkumab for treating moderate to severe plaque psoriasisTA521
Midostaurin for untreated acute myeloid leukaemiaTA523
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Intranasal phototherapy for allergic rhinitisHTG473
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or overNG36
Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapyHTG472
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Percutaneous balloon valvuloplasty for fetal critical aortic stenosisHTG471
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan IHTG467
Robot-assisted kidney transplantHTG468
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG469
Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucomaHTG470
Nerve transfer to partially restore upper limb function in tetraplegiaHTG466
Tocilizumab for treating giant cell arteritisTA518
Care and support of people growing older with learning disabilitiesNG96
Learning disabilities and behaviour that challenges: service design and deliveryNG93
Emergency and acute medical care in over 16s: service delivery and organisationNG94
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimenTA515
Cabozantinib for treating medullary thyroid cancerTA516
Physical activity and the environmentNG90
Brodalumab for treating moderate to severe plaque psoriasisTA511
Tivozanib for treating advanced renal cell carcinomaTA512
Obinutuzumab for untreated advanced follicular lymphomaTA513
Mosaicplasty for symptomatic articular cartilage defects of the kneeHTG463
Laparoscopic mesh pectopexy for apical prolapse of the uterus or vaginaHTG464
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the kneeTA508
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancerTA509
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis CTA507
People's experience in adult social care services: improving the experience of care and support for people using adult social care servicesNG86
Aortic valve reconstruction with processed bovine pericardiumHTG461
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiencyHST7
Pancreatic cancer in adults: diagnosis and managementNG85
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal womenTA160
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal womenTA161
Pirfenidone for treating idiopathic pulmonary fibrosisTA504
Intrabeam radiotherapy system for adjuvant treatment of early breast cancerTA501
Ibrutinib for treating relapsed or refractory mantle cell lymphomaTA502
Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancerTA503
Sore throat (acute): antimicrobial prescribingNG84
Ceritinib for untreated ALK-positive non-small-cell lung cancerTA500
Lenvatinib with everolimus for previously treated advanced renal cell carcinomaTA498

Results per page

  1. 10
  2. 25
  3. 50
  4. All